Presented by AMR Action Fund, with funding support from Pfizer, Shionogi, and MSD. Antimicrobial resistance (AMR) is one of the greatest public health threats today, according to the World Health ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...

AMR Action Fund led the biotech's recently-completed third-round financing with an undisclosed investment. "While this is a major milestone for the Fund, our work is just beginning.," said Skinner.

Alpha Metallurgical Resources, Inc. (AMR) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our ...

K grant to accelerate development of Glox Therapeutics' novel precision antibiotics targeting AMR lung infections in people ...

By Oliver Hirt ZURICH (Reuters) -Swiss biopharma company BioVersys said on Tuesday it plans to list on the Swiss stock exchange in the first quarter with an initial public offering that aims to raise ...

Alpha Metallurgical Resources, Inc. (NYSE:AMR – Get Free Report) shares hit a new 52-week low on Friday . The company traded as low as $185.00 and last traded at $186.45, with a volume of 18563 shares ...